Sign in
4

Changes in Ownership

COGNITION THERAPEUTICS INC Filed Acc 0001104659-25-123721

Chief Financial Officer gave up 9,360 shares (to pay taxes)

  • Chief Financial Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doyle John Brendan Chief Financial Officer 2025-12-18 Grant or award +30,000 455,350 D
Doyle John Brendan Chief Financial Officer 2025-12-18 Shares withheld for taxes −9,360 $1.50 $14,040 445,990 D
Loading xslF345X05/tm2534021-1_4seq1.xml…